Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical Science (London, England : 1979)|July 22, 2021
Fifty years of research on the brain renin-angiotensin system: what have we learned?Edwyn O Cruz-López, Estrellita Uijl, A H Jan DanserJournal of Cardiovascular Pharmacology|November 29, 2021
Perivascular Adipose Tissue in Vascular Function: Does Locally Synthesized Angiotensinogen Play a Role?Edwyn O Cruz-López, Estrellita Uijl, A H Jan DanserArteriosclerosis, Thrombosis, and Vascular Biology|October 19, 2023
Targeting Angiotensinogen With N-Acetylgalactosamine-Conjugated Small Interfering RNA to Reduce Blood PressureDien Ye, Edwyn O Cruz-López, Ho-Chou Tu, et al.Blood Pressure|October 10, 2024
Endothelin-1- and acetylcholine-mediated effects in human and rat vessels: impact of perivascular adipose tissue, diabetes, angiotensin II, and chemerinEdwyn O Cruz-López, Lunbo Tan, Daniël G Stolk, et al.Hypertension (Dallas, Tex. : 1979)|July 29, 2022
Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal DiseaseEdwyn O Cruz-López, Dien Ye, Congqing Wu, et al.Hypertension (Dallas, Tex. : 1979)|May 1, 2024
Counteracting Angiotensinogen Small-Interfering RNA-Mediated Antihypertensive Effects With REVERSIRDien Ye, Edwyn O Cruz-López, Richard van Veghel, et al.Journal of Hypertension|December 13, 2023
Combining renin-angiotensin system blockade and sodium-glucose cotransporter-2 inhibition in experimental diabetes results in synergistic beneficial effectsEdwyn O Cruz-López, Dien Ye, Daniel G Stolk, et al.British Journal of Pharmacology|September 15, 2022
Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetesEdwyn O Cruz-López, Liwei Ren, Estrellita Uijl, et al.Hypertension (Dallas, Tex. : 1979)|February 16, 2024
Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in PreeclampsiaLunbo Tan, Ans C M Kluivers, Edwyn O Cruz-López, et al.Pageof 1